Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- CheckyesterdayChange DetectedAdded navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment label, replacing the previous Intervention / Treatment. The page now also shows the recruitment status as 'No longer looking for participants', indicating that enrollment has ended.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision: v3.5.5 is now shown in the page's revision history, replacing the previous Revision: v3.5.4.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates an updated version of the referenced document or page metadata.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page footer version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site/version update and does not change the study details shown on the record.SummaryDifference0.0%

- Check58 days agoChange DetectedCollaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and the document revision advanced from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check86 days agoChange DetectedUpdated the revision label to v3.5.0 and removed the previous v3.4.3 entry.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.